Synovial Immunopathological Changes Associated with Successful Abatacept Therapy in a Case of Severe Refractory Psoriatic Arthritis
Overview
Affiliations
Cutolo M, Soldano S, Gotelli E, Montagna P, Campitiello R, Paolino S Arthritis Res Ther. 2021; 23(1):306.
PMID: 34952630 PMC: 8709961. DOI: 10.1186/s13075-021-02691-9.
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis.
Szentpetery A, Heffernan E, Gogarty M, Mellerick L, McCormack J, Haroon M Arthritis Res Ther. 2017; 19(1):158.
PMID: 28679449 PMC: 5498994. DOI: 10.1186/s13075-017-1364-3.
Abatacept in psoriatic arthritis: Case report and short review.
Ursini F, Naty S, Russo E, Grembiale R J Pharmacol Pharmacother. 2013; 4(Suppl 1):S29-32.
PMID: 24347977 PMC: 3853664. DOI: 10.4103/0976-500X.120943.
Macrophages in synovial inflammation.
Kennedy A, Fearon U, Veale D, Godson C Front Immunol. 2012; 2:52.
PMID: 22566842 PMC: 3342259. DOI: 10.3389/fimmu.2011.00052.
Ambarus C, Noordenbos T, de Hair M, Tak P, Baeten D Arthritis Res Ther. 2012; 14(2):R74.
PMID: 22494514 PMC: 3446447. DOI: 10.1186/ar3796.